Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Kunming Bondir Pharmaceutical Research is a specialized contract research organization (CRO) based in Kunming, China, that focuses on preclinical drug evaluation and animal model development. Leveraging the unique primate resources available in the Yunnan region, the company provides high-quality non-human primate (NHP) models for a variety of therapeutic areas, including metabolic, neurological, and cardiovascular diseases. Their services encompass pharmacokinetics, pharmacodynamics, and safety assessment to support global pharmaceutical and biotechnology clients. The company is recognized for its expertise in establishing complex disease models that closely mimic human pathology, facilitating more accurate translational research.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Kunming Bondir Pharmaceutical Research.